Tredje AP-fonden’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.98M | Sell |
12,202
-3,705
| -23% | -$1.21M | 0.03% | 151 |
|
|
2025
Q1 | $4.3M | Buy |
15,907
+6,165
| +63% | +$1.66M | 0.04% | 161 |
|
|
2024
Q4 | $2.29M | Sell |
9,742
-9,741
| -50% | -$2.29M | 0.02% | 247 |
|
|
2024
Q3 | $5.36M | Hold |
19,483
| – | – | 0.05% | 198 |
|
|
2024
Q2 | $4.73M | Sell |
19,483
-308
| -2% | -$74.8K | 0.05% | 190 |
|
|
2024
Q1 | $2.96M | Hold |
19,791
| – | – | 0.03% | 288 |
|
|
2023
Q4 | $3.79M | Sell |
19,791
-765
| -4% | -$146K | 0.05% | 239 |
|
|
2023
Q3 | $3.64M | Sell |
20,556
-1,812
| -8% | -$321K | 0.05% | 230 |
|
|
2023
Q2 | $4.25M | Sell |
22,368
-3,720
| -14% | -$707K | 0.06% | 219 |
|
|
2023
Q1 | $5.23M | Buy |
26,088
+1,824
| +8% | +$365K | 0.08% | 175 |
|
|
2022
Q4 | $5.77M | Buy |
24,264
+422
| +2% | +$100K | 0.1% | 154 |
|
|
2022
Q3 | $4.77M | Buy |
+23,842
| New | +$4.77M | 0.1% | 154 |
|
|
2018
Q2 | – | Sell |
-7,200
| Closed | -$858K | – | 400 |
|
|
2018
Q1 | $858K | Buy |
7,200
+3,550
| +97% | +$423K | 0.03% | 444 |
|
|
2017
Q4 | $464K | Buy |
+3,650
| New | +$464K | 0.02% | 516 |
|